- Home
- VTVT vs ELEV Comparison
VTVT vs ELEV Comparison
Compare VTVT & ELEV Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- VTVT
- ELEV
- Stock Information
- Founded
- VTVT 2015
- ELEV 2019
- Country
- VTVT United States
- ELEV United States
- Employees
- VTVT N/A
- ELEV N/A
- Industry
- VTVT Biotechnology: Pharmaceutical Preparations
- ELEV Biotechnology: Pharmaceutical Preparations
- Sector
- VTVT Health Care
- ELEV Health Care
- Exchange
- VTVT Nasdaq
- ELEV Nasdaq
- Market Cap
- VTVT N/A
- ELEV 22.0M
- IPO Year
- VTVT 2015
- ELEV 2021
- Fundamental
- Price
- VTVT $20.08
- ELEV $0.36
- Analyst Decision
- VTVT Strong Buy
- ELEV Buy
- Analyst Count
- VTVT 2
- ELEV 6
- Target Price
- VTVT $35.50
- ELEV $2.94
- AVG Volume (30 Days)
- VTVT 8.5K
- ELEV 996.3K
- Earning Date
- VTVT 05-20-2025
- ELEV 05-16-2025
- Dividend Yield
- VTVT N/A
- ELEV N/A
- EPS Growth
- VTVT N/A
- ELEV N/A
- EPS
- VTVT N/A
- ELEV N/A
- Revenue
- VTVT $1,017,000.00
- ELEV N/A
- Revenue This Year
- VTVT N/A
- ELEV N/A
- Revenue Next Year
- VTVT N/A
- ELEV N/A
- P/E Ratio
- VTVT N/A
- ELEV N/A
- Revenue Growth
- VTVT N/A
- ELEV N/A
- 52 Week Low
- VTVT $12.12
- ELEV $0.22
- 52 Week High
- VTVT $29.01
- ELEV $4.33
- Technical
- Relative Strength Index (RSI)
- VTVT 50.66
- ELEV 52.69
- Support Level
- VTVT $19.49
- ELEV $0.34
- Resistance Level
- VTVT $22.37
- ELEV $0.36
- Average True Range (ATR)
- VTVT 1.28
- ELEV 0.03
- MACD
- VTVT -0.14
- ELEV 0.00
- Stochastic Oscillator
- VTVT 27.61
- ELEV 50.00
About ELEV Elevation Oncology Inc. Common stock
Elevation Oncology Inc is an oncology company focused on the development of selective cancer therapies to treat patients across a range of solid tumors with unmet medical needs. Its product candidate, EO-3021 (also known as SYSA1801 or CPO102), is an ADC comprised of a fully human anti-Claudin 18.2 immunoglobulin G1 (IgG1) monoclonal antibody (mAb) site-specifically conjugated with a cleavable linker to the cytotoxic monomethyl auristatin E (MMAE) payload. Claudin 18.2 is overexpressed in several types of cancers, including gastric, esophageal, pancreatic, ovarian and lungon.